Senior Scientist ETCT

We create a place where people can grow, be their best, be safe, and feel welcome, valued and included. We offer a competitive salary, an annual bonus based on company performance, healthcare and wellbeing programmes, pension plan membership, and shares and savings programme.

We embrace modern work practises; our Performance with Choice programme offers a hybrid working model, empowering you to find the optimal balance between remote and in-office work.

Discover more about our company wide benefits and life at GSK on our webpage Life at GSK | GSK

Senior Scientist ETCT

The Extracellular Targeted Cancer Therapeutics (ETCT) Biology Unit within the Oncology Research Unit is seeking an experienced

Scientist

to contribute to programs in pre-clinical and early clinical phases in the targeted biologics portfolio focusing on ADCs & TCEs.

The candidate will work within multi-disciplinary program teams by contributing to biology strategy, delivering molecule mechanism of action and potency data and providing input into other functions such as pharmacokinetics, non-clinical safety, biomarkers and clinical development. The successful applicant will have strong technical expertise in a variety of lab methods and ideally experience working in cross-functional matrix teams in the oncology space.

We are looking for this role to be based at Stevenage site only.

In this role you will…

Contribute to cross-functional matrix teams to deliver basic and translational critical path biology work packages to support pre-clinical and early clinical biologics programs.

Work independently to design and execute impactful experiments which influence the direction of assets in the ETCT BU portfolio.

Champion innovative experimental techniques/technologies internally and at CROs.

Build communication networks across the Research organization.

Train and mentor junior scientists and complementary workers.

Why you?

Basic Qualifications:

We are looking for professionals with these required skills to achieve our goals:

BSc or higher degree in Cell Biology, Pharmacology, Immunology or related fields.

Demonstrated technical expertise in cell culture, general lab instrumentation, cell-based assays such as proliferation, immunoassays such as ELISA and experience with Flow Cytometry, including analysis of data.

Expertise in cancer biology

Attention to detail and proficient reasoning skills in experimental design, data analysis, statistical methods and interpretation.

Independence, problem-solving abilities, self-motivation, resourcefulness, and the ability to work in a fast-paced team environment.

Preferred Qualifications:

If you have the following characteristics, it would be a plus:

Experience in working in cross-functional drug discovery project teams to develop novel therapeutic platforms.

Experience with the design and testing of biologics.

Strong peer-reviewed publication, public speaking / presentation and/or inventorship record.

Closing Date for Applications – 14/05/2026

Please take a copy of the Job Description, as this will not be available post closure of the advert.

When applying for this role, please use the ‘cover letter’ of the online application or your CV to describe how you meet the competencies for this role, as outlined in the job requirements above. The information that you have provided in your cover letter and CV will be used to assess your application.

GSK R&D

At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people over the next 10 years. R&D is committed to discovering and delivering transformational vaccines and medicines to prevent and change the course of disease. Science and technology are coming together in a way they never have before, and we have strong tech-enabled capabilities that allow us to build a deeper understanding of the patient, human biology and disease mechanisms, and transform medical discovery.  We are revolutionising the way we do R&D. We’re uniting science, technology and talent to get ahead of disease together.

Find out more:

Our approach to R&D

.